HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-DEC-18 6NFI TITLE BTK IN COMPLEX WITH INHIBITOR N-(3-{[(2,6-DIMETHYLPHENYL) TITLE 2 METHYL]AMINO}-7-METHOXYINDENO[1,2-C]PYRAZOL-6-YL)METHANESULFONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 392-659); COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE, ATK, B-CELL PROGENITOR COMPND 6 KINASE, BPK, BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRUTON TYROSINE KINASE, BTK, KINASE, BTK INHIBITOR, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.L.DAMM-GANAMET,T.MIRZADEGAN REVDAT 3 11-OCT-23 6NFI 1 REMARK REVDAT 2 12-JUN-19 6NFI 1 JRNL REVDAT 1 13-MAR-19 6NFI 0 JRNL AUTH K.L.DAMM-GANAMET,N.ARORA,S.BECART,J.P.EDWARDS,A.D.LEBSACK, JRNL AUTH 2 H.M.MCALLISTER,M.I.NELEN,N.L.RAO,L.WESTOVER,J.J.M.WIENER, JRNL AUTH 3 T.MIRZADEGAN JRNL TITL ACCELERATING LEAD IDENTIFICATION BY HIGH THROUGHPUT VIRTUAL JRNL TITL 2 SCREENING: PROSPECTIVE CASE STUDIES FROM THE PHARMACEUTICAL JRNL TITL 3 INDUSTRY. JRNL REF J.CHEM.INF.MODEL. V. 59 2046 2019 JRNL REFN ESSN 1549-960X JRNL PMID 30817167 JRNL DOI 10.1021/ACS.JCIM.8B00941 REMARK 2 REMARK 2 RESOLUTION. 2.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 10900 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1058 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.41 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.47 REMARK 3 REFLECTION IN BIN (WORKING SET) : 677 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 70 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2005 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.67000 REMARK 3 B22 (A**2) : 1.75000 REMARK 3 B33 (A**2) : -3.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.447 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.264 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.168 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.379 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2013 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1367 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2734 ; 1.072 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3266 ; 0.975 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 242 ; 5.639 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 85 ;30.112 ;23.529 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 323 ;12.467 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;11.442 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 297 ; 0.062 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2218 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 436 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 474 REMARK 3 ORIGIN FOR THE GROUP (A): -12.2340 1.3960 -11.5120 REMARK 3 T TENSOR REMARK 3 T11: 0.5139 T22: 0.2641 REMARK 3 T33: 0.3797 T12: 0.0561 REMARK 3 T13: -0.0201 T23: 0.0481 REMARK 3 L TENSOR REMARK 3 L11: 2.4850 L22: 9.1473 REMARK 3 L33: 1.9347 L12: -2.9833 REMARK 3 L13: 0.3945 L23: 1.5962 REMARK 3 S TENSOR REMARK 3 S11: -0.1603 S12: -0.2318 S13: 0.2828 REMARK 3 S21: 0.7957 S22: 0.0452 S23: 0.2173 REMARK 3 S31: -0.3775 S32: -0.2141 S33: 0.1152 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 475 A 1380 REMARK 3 ORIGIN FOR THE GROUP (A): -13.8710 -24.9780 -16.2380 REMARK 3 T TENSOR REMARK 3 T11: 0.0063 T22: 0.1158 REMARK 3 T33: 0.0777 T12: 0.0248 REMARK 3 T13: 0.0029 T23: 0.0173 REMARK 3 L TENSOR REMARK 3 L11: 3.1355 L22: 3.3682 REMARK 3 L33: 4.5827 L12: 0.6406 REMARK 3 L13: 0.3132 L23: -0.8778 REMARK 3 S TENSOR REMARK 3 S11: 0.0054 S12: 0.0453 S13: 0.0357 REMARK 3 S21: 0.0387 S22: -0.0068 S23: -0.0498 REMARK 3 S31: -0.0438 S32: -0.3186 S33: 0.0013 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6NFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000238348. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99987 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11994 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.410 REMARK 200 RESOLUTION RANGE LOW (A) : 60.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.41 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.10 REMARK 200 R MERGE FOR SHELL (I) : 0.48500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1K2P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% W/V PEG5000 MME, 0.1 M MES, PH REMARK 280 6.5, 0.1 M AMMONIUM SULFATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.49100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.77500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.49100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.77500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 411 REMARK 465 GLN A 412 REMARK 465 PHE A 413 REMARK 465 GLY A 414 REMARK 465 LYS A 433 REMARK 465 GLU A 434 REMARK 465 GLY A 435 REMARK 465 ARG A 468 REMARK 465 PRO A 469 REMARK 465 LEU A 542 REMARK 465 SER A 543 REMARK 465 ARG A 544 REMARK 465 TYR A 545 REMARK 465 VAL A 546 REMARK 465 LEU A 547 REMARK 465 ASP A 548 REMARK 465 ASP A 549 REMARK 465 GLU A 550 REMARK 465 TYR A 551 REMARK 465 THR A 552 REMARK 465 SER A 553 REMARK 465 SER A 554 REMARK 465 VAL A 555 REMARK 465 GLY A 556 REMARK 465 SER A 557 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 400 CD CE NZ REMARK 480 LYS A 406 CG CD CE NZ REMARK 480 GLU A 407 CG CD OE1 OE2 REMARK 480 LYS A 417 CG CD CE NZ REMARK 480 ARG A 422 NE CZ NH1 NH2 REMARK 480 GLN A 424 CG CD OE1 NE2 REMARK 480 LYS A 430 CG CD CE NZ REMARK 480 SER A 436 OG REMARK 480 MET A 437 CG SD CE REMARK 480 ASP A 440 CG OD1 OD2 REMARK 480 GLU A 441 CG CD OE1 OE2 REMARK 480 ILE A 443 CG1 CG2 CD1 REMARK 480 GLU A 444 CG CD OE1 OE2 REMARK 480 GLU A 445 CG CD OE1 OE2 REMARK 480 LYS A 447 CG CD CE NZ REMARK 480 LYS A 466 CE NZ REMARK 480 GLN A 467 CD OE1 NE2 REMARK 480 GLU A 488 CG CD OE1 OE2 REMARK 480 MET A 489 CG SD CE REMARK 480 ARG A 490 CG CD NE CZ NH1 NH2 REMARK 480 GLN A 496 CG CD OE1 NE2 REMARK 480 GLN A 516 CG CD OE1 NE2 REMARK 480 LYS A 558 CG CD CE NZ REMARK 480 LYS A 573 NZ REMARK 480 GLU A 608 CG CD OE1 OE2 REMARK 480 GLU A 624 CG CD OE1 OE2 REMARK 480 LYS A 637 CE NZ REMARK 480 LYS A 645 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 466 50.68 -112.68 REMARK 500 ARG A 520 -4.69 75.98 REMARK 500 ASP A 521 45.08 -149.91 REMARK 500 PHE A 540 98.60 -22.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KLP A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 703 DBREF 6NFI A 392 659 UNP Q06187 BTK_HUMAN 392 659 SEQRES 1 A 268 TYR GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE SEQRES 2 A 268 LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS SEQRES 3 A 268 TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS SEQRES 4 A 268 MET ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE SEQRES 5 A 268 GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS SEQRES 6 A 268 LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO SEQRES 7 A 268 ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU SEQRES 8 A 268 LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR SEQRES 9 A 268 GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA SEQRES 10 A 268 MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP SEQRES 11 A 268 LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL SEQRES 12 A 268 VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU SEQRES 13 A 268 ASP ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO SEQRES 14 A 268 VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS SEQRES 15 A 268 PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU SEQRES 16 A 268 MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU SEQRES 17 A 268 ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN SEQRES 18 A 268 GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS SEQRES 19 A 268 VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA SEQRES 20 A 268 ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE SEQRES 21 A 268 LEU ASP VAL MET ASP GLU GLU SER HET KLP A 701 29 HET SO4 A 702 5 HET SO4 A 703 5 HETNAM KLP N-(3-{[(2,6-DIMETHYLPHENYL)METHYL]AMINO}-7- HETNAM 2 KLP METHOXYINDENO[1,2-C]PYRAZOL-6-YL)METHANESULFONAMIDE HETNAM SO4 SULFATE ION FORMUL 2 KLP C21 H22 N4 O3 S FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *33(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 LEU A 452 1 15 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 GLN A 494 LYS A 515 1 22 HELIX 5 AA5 ALA A 523 ARG A 525 5 3 HELIX 6 AA6 PRO A 560 SER A 564 5 5 HELIX 7 AA7 PRO A 565 SER A 572 1 8 HELIX 8 AA8 SER A 575 SER A 592 1 18 HELIX 9 AA9 THR A 602 GLN A 612 1 11 HELIX 10 AB1 SER A 623 CYS A 633 1 11 HELIX 11 AB2 LYS A 637 ARG A 641 5 5 HELIX 12 AB3 THR A 643 SER A 659 1 17 SHEET 1 AA1 5 LEU A 402 GLY A 409 0 SHEET 2 AA1 5 VAL A 416 TRP A 421 -1 O VAL A 416 N LEU A 408 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 SITE 1 AC1 13 LEU A 408 ALA A 428 LYS A 430 ILE A 472 SITE 2 AC1 13 THR A 474 GLU A 475 TYR A 476 MET A 477 SITE 3 AC1 13 ALA A 478 GLY A 480 CYS A 481 SER A 538 SITE 4 AC1 13 PHE A 540 SITE 1 AC2 5 LYS A 595 TYR A 617 PRO A 619 HIS A 620 SITE 2 AC2 5 HOH A 813 SITE 1 AC3 6 ARG A 520 TRP A 563 SER A 564 PRO A 565 SITE 2 AC3 6 SER A 578 HOH A 801 CRYST1 72.982 105.550 38.205 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013702 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009474 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026175 0.00000